Intended for healthcare professionals


Better screening needed for sickle cell and thalassaemia

BMJ 2000; 321 doi: (Published 29 July 2000) Cite this as: BMJ 2000;321:260
  1. Jenny Blythe
  1. BMJ

    Universal antenatal screening for sickle cell disease and thalassaemia may be cost effective in some areas of the United Kingdom, says a report from the Wessex Institute for Health Research and Development.

    Universal antenatal and neonatal screening was previously recommended in areas in which 15% …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription